SEARCH

SEARCH BY CITATION

References

  • 1
    McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED., Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116122.
  • 2
    McDonald GB, Hinds MS, Fisher DL, Schoch HG, Wolford JL, Banaji M, Hardin BJ, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255267.
  • 3
    Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 30053020.
  • 4
    Blostein MD, Paltiel OB, Thibault A, Rybka WB. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 439443.
  • 5
    Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB., Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 11711180.
  • 6
    Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J, Tassies MD, et al. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease. Ann Hematol 1993; 66: 7780.
  • 7
    Shulman HM, Gooley T, Dudley MD, Kofler T, Feldman R, Dwyer D, McDonald GB. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995; 59: 10151022.
  • 8
    Langnas AN, Sorrell MF. The Budd-Chiari syndrome: a therapeutic Gordian knot? Semin Liver Dis 1993; 13: 352359.
  • 9
    Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB., Venooclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 17291736.
  • 10
    Bearman SI, Hinds MS, Wolford JL, Petersen FB, Nugent DL, Slichter SJ, Shulman HM, et al. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant 1990; 5: 407411.
  • 11
    Attal M, Huguet F, Rubie H, Huynh A, Charlet J-P, Payen J-L, Voigt J-J, et al. Prevention of hepatic veno-occlusive disease of the liver after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective randomized trial. Blood 1992; 79: 28342840.
  • 12
    Marsa-Vila L, Gorin NC, Laport JP, Labopin M, Dupuy-Montbrun MC, Fouillard L, Isnard F, et al. Prophylactic heparin does not prevent liver veno-occlusive following autologous bone marrow transplantation. Eur J Hematol 1991; 47: 346354.
  • 13
    Bearman SI, Shuhart MC, Hinds MS, McDonald GB. Recombinant human tissue plasminogen activator for the treatment of established severe veno-oclusive disease of the liver after bone marrow transplantation. Blood 1992; 80: 24582462.
  • 14
    Bearman SI, Shen DD, Hinds MS, Hill HA, McDonald GB. A phase I/II study of prostaglandin E1 for the prevention of hepatic venooclusive disease after bone marrow transplantation. Br J Hematol 1993; 84: 724730.
  • 15
    Henderson JM, Warren WD, Millikan WJ, Galloway JR, Kawasaki S, Stahl RL, Hertzler G. Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome. Am J Surg 1990; 159: 4148.
  • 16
    Kohli V, Pande GK, Dev V, Reddy KS, Kaul U, Nundy S. Management of hepatic venous outflow obstruction. Lancet 1993; 342: 718722.
  • 17
    Murray JA, LaBrecque DR, Gingrich RD, Pringle KG, Mitros FA. Successful treatment of hepatic venocclusive disease in a bone marrow transplant patients with side to side portacaval shunt. Gastroenterology 1987; 92: 10731077.
  • 18
    Jacobson BK, Kalayoglu M. Effective early treatment of hepatic venocclusive disease with central splenorenal shunt in an infant. J Pediatr Surg 1992; 27: 531533.
  • 19
    Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, et al. Transjugular intrahepatic portal systemic shunt stent procedure for refractory ascites. N Engl J Med 1995; 332: 11921197.
  • 20
    Zager RA, O'Quigley J, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED., Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 1989; 13: 210216.
  • 21
    Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89: 15201522.
  • 22
    Ochs A, Sellinger M, Haag K, Noldge G, Herbst EW, Walter E, Gerok W, et al. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993; 18: 217225.
  • 23
    Michielsen PP, Pelckmans PA, d'Archambeau OC, DeSchepper AM, Van Marck EA, Meerman L, Haagsma EB, et al. Transjugular intrahepatic portosystemic shunt improves liver function in veno-occlusive disease. J Hepatol 1995; 21: 685686.
  • 24
    Shulman HM, Hinterberger W. Hepatic venoocclusive disease—liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197214.
  • 25
    Holler E, Kolb HJ, Moller A, Kempeni J, Liesenfeld S, Pechumer H, Lehmached W, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 10111016.
  • 26
    Tanaka J, Imamura M, Kasai M, Masauzi N, Watanabe M, Matsuura A, Morii K, et al. Rapid analysis of tumor necrosis factor alpha mRNA expression during venoocclusive disease of the liver after allogeneic bone marrow transplantation. Transplantation 1993; 55: 430432.